(Q38481036)

3 September 2017

Total and specific polyphenol intakes in midlife are associated with cognitive function measured 13 years later (English)

1 reference

3 September 2017

1 reference

Emmanuelle Kesse-Guyot

series ordinal

1

object named as

Emmanuelle Kesse-Guyot

1 reference

3 September 2017

6

Serge Hercberg

1 reference

3 September 2017

7

Pilar Galan

1 reference

3 September 2017

4

Mathilde Touvier

1 reference

3 September 2017

3

Valentina A Andreeva

1 reference

3 September 2017

2

Léopold Fezeu

1 reference

3 September 2017

5

Augustin Scalbert

1 reference

PubMed ID

22090468

3 September 2017

language of work or name

English

0 references

publication date

16 November 2011

1 reference

3 September 2017

1 reference

3 September 2017

142

1 reference

3 September 2017

76-83

1 reference

3 September 2017

1

1 reference

Dietary intake of 337 polyphenols in French adults

3 September 2017

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.144428

Oxidative stress and Alzheimer's disease: dietary polyphenols as potential therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.144428

Benefits from dietary polyphenols for brain aging and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.144428

The neuroprotective potential of flavonoids: a multiplicity of effects

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.144428

Flavonoids and cognition: the molecular mechanisms underlying their behavioural effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.144428

Fruit and vegetable juices and Alzheimer's disease: the Kame Project

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.144428

Cognitive function and tea consumption in community dwelling older Chinese in Singapore

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.144428

Dietary intake of antioxidants and risk of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.144428

Flavonoid intake and cognitive decline over a 10-year period.

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.144428

Intake of flavonoids and risk of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.144428

The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.144428

Adherence to nutritional recommendations and subsequent cognitive performance: findings from the prospective Supplementation with Antioxidant Vitamins and Minerals 2 (SU.VI.MAX 2) study

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.144428

Memory evaluation with a new cued recall test in patients with mild cognitive impairment and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.144428

The CES-D Scale: A Self-Report Depression Scale for Research in the General Population

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.144428

Prodromal Alzheimer's disease: successive emergence of the clinical symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.144428

Beneficial effects of fruit extracts on neuronal function and behavior in a rodent model of accelerated aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.144428

Flavonoids and brain health: multiple effects underpinned by common mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.144428

Beyond antioxidants: the cellular and molecular interactions of flavonoids and how these underpin their actions on the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.144428

Caffeic acid, tyrosol and p-coumaric acid are potent inhibitors of 5-S-cysteinyl-dopamine induced neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.144428

Health behaviors from early to late midlife as predictors of cognitive function: The Whitehall II study

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.144428

Alzheimer's disease is incurable but preventable

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.144428

Very early detection of Alzheimer neuropathology and the role of brain reserve in modifying its clinical expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.144428

21 January 2018

Identifiers

DOI

10.3945/JN.111.144428

1 reference

3 September 2017

1 reference

PubMed ID

22090468